Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on October 5, 2026

Oct. 5, 2026

enQase Appoints Brian Scott as Defense and National Security Advisor

Indeterminate EIN Presswire

Oct. 5, 2026

Freedom Behavioral Health Solutions Expands Killeen Presence With Move to New Location

Indeterminate EIN Presswire

Oct. 5, 2026

Young Clinical Investigator Programme, BlueCloudX® Equip Next Generation of African Clinical Research Leaders

Indeterminate EIN Presswire

Oct. 5, 2026

Moyae Partners with Advanced Data Systems to Deliver an End-to-End Platform for Vision-Care Practices

Indeterminate EIN Presswire

Oct. 5, 2026

TriCelX Earns AABB Accreditation — Three FDA-Cleared Trials, One Biotherapeutic, One Standard

Indeterminate EIN Presswire

Oct. 5, 2026

Legacy Opens Acres Homes Clinic to Expand Access to Care in a Historic Houston Community

Indeterminate GlobeNewswire

Oct. 5, 2026

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 5, 2026

U.S. Searches for 'Genogram' Nearly Double Each School Term, With October the Busiest Month

Indeterminate EIN Presswire

Oct. 5, 2026

Citizens Commission on Human Rights International: Mental Health Awareness Week Is Not Awareness When Forced Treatment Goes Unchallenged

Indeterminate GlobeNewswire

Oct. 5, 2026

Vaxcyte Announces Commencement of Proposed Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes

Indeterminate GlobeNewswire

Oct. 5, 2026

Aligos Therapeutics Announces Five Abstracts Accepted for Presentation at The Liver Meeting® 2026

Indeterminate GlobeNewswire

Oct. 5, 2026

Inspire Medical Systems, Inc. to Report Third Quarter 2026 Financial Results on November 2, 2026

Indeterminate GlobeNewswire

Oct. 5, 2026

Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team

Indeterminate GlobeNewswire

Oct. 5, 2026

Korro Announces First Cohort Dosed in Phase 1/2 Clinical Trial (ANCHOR) for KRRO-121

Indeterminate GlobeNewswire

Oct. 5, 2026

Standard BioTools Announces Agreement to Sell Microfluidics Business to ARCHIMED

Indeterminate GlobeNewswire

Oct. 5, 2026

Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504

Indeterminate GlobeNewswire

Oct. 5, 2026

Eledon Pharmaceuticals Announces Presentation at the American Society of Nephrology Kidney Week 2026 Annual Meeting

Indeterminate GlobeNewswire

Oct. 5, 2026

iCell Gene Therapeutics Announces Upcoming Conference Presentations

Indeterminate GlobeNewswire

Oct. 5, 2026

ORIC® Pharmaceuticals Announces Agreement with Cancer Research UK to Advance a Potential First-in-Class CIP2A-Targeted Therapy Into Clinical Development

Indeterminate GlobeNewswire

Oct. 5, 2026

Spyre Therapeutics Announces Proposed Public Offering of its Common Stock

Indeterminate GlobeNewswire